Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Troxacitabine in acute leukemia
R. Swords, F. Giles
*
*
Corresponding author for this work
Medicine, Hematology Oncology Division
Research output
:
Contribution to journal
›
Review article
›
peer-review
15
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Troxacitabine in acute leukemia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Acute Leukemia
100%
Troxacitabine
100%
Pharmacokinetics
20%
Hematological Malignancies
20%
Malignancy
20%
Clinical Efficacy
20%
Tolerability
20%
Pharmacology
20%
Antiviral Activity
20%
Clinical Development
20%
Mode of Action
20%
Cytotoxic Activity
20%
Unnatural
20%
Sulfur
20%
Solid Malignancies
20%
Lamivudine
20%
Stereochemistry
20%
Cytarabine
20%
Ara-C
20%
L-nucleosides
20%
Cytotoxic Potency
20%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Leukemia
100%
Troxacitabine
100%
Cytarabine
33%
Tolerability
16%
Sulfur
16%
Antiviral Activity
16%
Hematologic Malignancy
16%
Lamivudine
16%
Nucleoside
16%
Pharmacokinetics
16%
Cytotoxicity
16%